Home / Stocks / SUPN

SUPN insider trading

SUPERNUS PHARMACEUTICALS, INC. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy
—

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-03-18Bhatt Padmanabh P.
Sr. VP of IP, CSO
Sold84,114$50.25$4.2M
2026-03-16Khattar Jack A.
President, CEO
Sold24,138$50.09$1.2M
2025-10-10Khattar Jack A.
President, CEO
Sold58,371$50.55$3.0M
2025-10-10NEWHALL CHARLES W III
Director
Sold23,800$50.73$1.2M
2025-10-02Khattar Jack A.
President, CEO
Sold40,173$48.07$1.9M
2025-09-24Khattar Jack A.
President, CEO
Sold29,513$47.23$1.4M
2025-09-08Khattar Jack A.
President, CEO
Sold55,578$46.01$2.6M
2025-08-29Khattar Jack A.
President, CEO
Sold24,150$45.12$1.1M
2025-08-08Khattar Jack A.
President, CEO
Sold140,000$42.02$5.9M
2024-11-12Khattar Jack A.
President, CEO
Sold125,000$36.29$4.5M
2024-11-08Khattar Jack A.
President, CEO
Sold125,000$36.68$4.6M

See SUPN on the chart

Every insider buy and sell for SUPN plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.